Evidence map›Paper›PMID 33479623›Full record

ArticleRSC medicinal chemistry2020

New chemical agents based on adamantane-monoterpene conjugates against orthopoxvirus infections.

Evgenii V Suslov, Evgenii S Mozhaytsev, Dina V Korchagina, Nikolay I Bormotov, Olga I Yarovaya, Konstantin P Volcho, Olga A Serova, Alexander P Agafonov, Rinat A Maksyutov, Larisa N Shishkina and 1 more

Open access · greenAbstract read
In one paragraph

Article in RSC medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evaluation of antiviral activity of terpenophenols and some of theirRussian chemical bulletin = Izvestiia Akademii nauk. Seriia khimicheskaia · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Evgenii V SuslovNovosibirsk Institute of Organic Chemistry , Siberian Branch of the Russian Academy of Sciences , Lavrentjev Avenue 9 , 630090 Novosibirsk , Russia . Email: suslov@nioch.nsc.ru.ORCID 0000-0003-0988-0502
Evgenii S MozhaytsevNovosibirsk Institute of Organic Chemistry , Siberian Branch of the Russian Academy of Sciences , Lavrentjev Avenue 9 , 630090 Novosibirsk , Russia . Email: suslov@nioch.nsc.ru.
Dina V KorchaginaNovosibirsk Institute of Organic Chemistry , Siberian Branch of the Russian Academy of Sciences , Lavrentjev Avenue 9 , 630090 Novosibirsk , Russia . Email: suslov@nioch.nsc.ru.
Nikolay I BormotovDepartment of Prevention and Treatment of Especially Dangerous Infections , State Research Center of Virology and Biotechnology VECTOR , Koltsovo , Novosibirsk Region , 630559 , Russian Federation.
Olga I YarovayaNovosibirsk Institute of Organic Chemistry , Siberian Branch of the Russian Academy of Sciences , Lavrentjev Avenue 9 , 630090 Novosibirsk , Russia . Email: suslov@nioch.nsc.ru.ORCID 0000-0002-2333-4893
Konstantin P VolchoNovosibirsk Institute of Organic Chemistry , Siberian Branch of the Russian Academy of Sciences , Lavrentjev Avenue 9 , 630090 Novosibirsk , Russia . Email: suslov@nioch.nsc.ru.
Olga A SerovaDepartment of Prevention and Treatment of Especially Dangerous Infections , State Research Center of Virology and Biotechnology VECTOR , Koltsovo , Novosibirsk Region , 630559 , Russian Federation.
Alexander P AgafonovDepartment of Prevention and Treatment of Especially Dangerous Infections , State Research Center of Virology and Biotechnology VECTOR , Koltsovo , Novosibirsk Region , 630559 , Russian Federation.
Rinat A MaksyutovDepartment of Prevention and Treatment of Especially Dangerous Infections , State Research Center of Virology and Biotechnology VECTOR , Koltsovo , Novosibirsk Region , 630559 , Russian Federation.
Larisa N ShishkinaDepartment of Prevention and Treatment of Especially Dangerous Infections , State Research Center of Virology and Biotechnology VECTOR , Koltsovo , Novosibirsk Region , 630559 , Russian Federation.
Nariman F SalakhutdinovNovosibirsk Institute of Organic Chemistry , Siberian Branch of the Russian Academy of Sciences , Lavrentjev Avenue 9 , 630090 Novosibirsk , Russia . Email: suslov@nioch.nsc.ru.
State Research Center of Virology and Biotechnology VECTOR · RUNovosibirsk Institute of Organic Chemistry · RUNovosibirsk State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, the spectrum of agents against orthopoxviruses, in particular smallpox, is very narrow. Despite the fact that smallpox is well controlled, there is, for many reasons, a real threat of epidemics associated with this or a similar virus. In order to search for new low molecular weight orthopoxvirus inhibitors, a series of amides combining adamantane and monoterpene moieties were synthesized using 1- and 2-adamantanecarboxylic acids as well as myrtenic, citronellic and camphorsulfonic acids as acid components. The produced compounds exhibited high activity against the vaccinia virus (an enveloped virus belonging to the poxvirus family), which was combined with low cytotoxicity. Some compounds had a selectivity index higher than that of the reference drug cidofovir; the highest SI = 1123 was exhibited by 1-adamantanecarboxylic acid amide containing the (-)-10-amino-2-pinene moiety. The produced compounds demonstrated inhibitory activity against other orthopoxviruses: cowpox virus (SI = 30-406) and ectromelia virus (mousepox virus, SI = 39-707).

Identifiers

PMID33479623
PMCPMC7651861
OpenAlexW3047450297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.